Search
for
Sort by
Research 841–870 of 1000+
- Immune therapies for alopecia areata: evidence and new perspectives
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
- Is the severity of alopecia areata associated with arterial stiffness?
- Increased Expression of Zyxin and Its Potential Function in Androgenetic Alopecia
- An Unusual Case of Contact Dermatitis
- Disease severity scoring systems in dermatology
- Hair loss and its management in children
- Hereditary Hypotrichosis and Localized Morphea: A New Clinical Entity
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- Advances in Hair Diseases
- Autoimmune thyroid disease and human health: a systematic review of Mendelian randomization studies
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Skin manifestations of endocrine diseases
- Disorders of hair growth and the pilosebaceous unit: Facts and controversies
- Tacrolimus in Dermatology
- Restoring neuropetide Y levels in the hypothalamus ameliorates premature aging phenotype in mice
- Efficacy and safety of baricitinib in patients with refractory alopecia areata
- Chemokine C-C Motif Ligand 7 (CCL7), a Biomarker of Atherosclerosis, Is Associated with the Severity of Alopecia Areata: A Preliminary Study
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Oxidative stress and antioxidant markers in patients with alopecia areata: A comparative cross-sectional study
- Alopecia areata: medical treatments
- Dermatopathology of Common Hair Problems
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Drug Survival and Long-term Outcome of Tofacitinib in Patients with Alopecia Areata: A Retrospective Study
- Alopecia – New building blocks
- Study of the Thyroid Profile of Patients with Alopecia
- Primary Care of Adult Women